Argyle Capital Management LLC Buys 200 Shares of CVS Health Corporation $CVS

Argyle Capital Management LLC raised its stake in shares of CVS Health Corporation (NYSE:CVS) by 0.7% during the 2nd quarter, according to its most recent filing with the SEC. The firm owned 30,417 shares of the pharmacy operator’s stock after acquiring an additional 200 shares during the period. Argyle Capital Management LLC’s holdings in CVS Health were worth $2,098,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of the stock. Jennison Associates LLC lifted its stake in shares of CVS Health by 503.8% in the 1st quarter. Jennison Associates LLC now owns 1,896,341 shares of the pharmacy operator’s stock worth $128,477,000 after purchasing an additional 1,582,257 shares during the period. Cantor Fitzgerald Investment Advisors L.P. lifted its stake in shares of CVS Health by 1.6% in the 2nd quarter. Cantor Fitzgerald Investment Advisors L.P. now owns 409,735 shares of the pharmacy operator’s stock worth $28,264,000 after purchasing an additional 6,615 shares during the period. Cerity Partners LLC lifted its stake in shares of CVS Health by 25.0% in the 1st quarter. Cerity Partners LLC now owns 648,266 shares of the pharmacy operator’s stock worth $43,920,000 after purchasing an additional 129,535 shares during the period. Bank of New York Mellon Corp lifted its stake in shares of CVS Health by 2.1% in the 1st quarter. Bank of New York Mellon Corp now owns 8,981,262 shares of the pharmacy operator’s stock worth $608,481,000 after purchasing an additional 183,813 shares during the period. Finally, Brandywine Global Investment Management LLC raised its stake in CVS Health by 20.1% during the 1st quarter. Brandywine Global Investment Management LLC now owns 3,421,519 shares of the pharmacy operator’s stock worth $231,808,000 after acquiring an additional 572,533 shares during the period. Institutional investors own 80.66% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have commented on CVS shares. Wolfe Research raised their target price on shares of CVS Health from $80.00 to $85.00 and gave the stock an “outperform” rating in a research note on Monday, September 22nd. Morgan Stanley raised their target price on shares of CVS Health from $80.00 to $82.00 and gave the stock an “overweight” rating in a research note on Friday, August 1st. Weiss Ratings restated a “hold (c-)” rating on shares of CVS Health in a research note on Saturday, September 27th. Robert W. Baird upgraded shares of CVS Health from a “neutral” rating to an “outperform” rating and raised their target price for the stock from $71.00 to $82.00 in a research note on Thursday, August 14th. Finally, Baird R W upgraded shares of CVS Health from a “hold” rating to a “strong-buy” rating in a research note on Thursday, August 14th. Two analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $79.80.

Insider Transactions at CVS Health

In related news, Director Anne A. Finucane sold 7,500 shares of the firm’s stock in a transaction on Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total value of $532,650.00. Following the completion of the sale, the director directly owned 22,156 shares in the company, valued at $1,573,519.12. This trade represents a 25.29% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.22% of the stock is currently owned by corporate insiders.

CVS Health Trading Down 0.2%

CVS stock opened at $76.78 on Friday. The firm has a fifty day moving average price of $71.98 and a 200 day moving average price of $67.59. CVS Health Corporation has a fifty-two week low of $43.56 and a fifty-two week high of $79.20. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.62 and a current ratio of 0.80. The firm has a market cap of $97.38 billion, a PE ratio of 21.45, a price-to-earnings-growth ratio of 0.85 and a beta of 0.60.

CVS Health (NYSE:CVS) last posted its earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share for the quarter, beating analysts’ consensus estimates of $1.46 by $0.35. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The firm had revenue of $98.92 billion during the quarter, compared to analyst estimates of $94.87 billion. During the same period last year, the firm posted $1.83 earnings per share. CVS Health’s revenue for the quarter was up 8.4% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. Sell-side analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, November 3rd. Investors of record on Thursday, October 23rd will be issued a $0.665 dividend. The ex-dividend date of this dividend is Thursday, October 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.5%. CVS Health’s dividend payout ratio (DPR) is 74.30%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.